Meetings
- Upcoming Meeting: Prescription Drug Affordability Board Stakeholder Council (PDASC) Meeting- June 23, 2025 at 2:00PM. Please visit the Stakeholder Council page for more information and registration information.
- New! Prescription Drug Affordability Board Meeting- June 23, 2025 at 9:00AM. Please visit the Board page for more information and registration information.
Comment Period:
Please visit the Prescription Drug Affordability Board's,
Cost Review Study Process page to view the Dossiers for Farxiga and Jardiance, posted on June 18, 2025.
For each prescription drug product, the Board requests comment on the drug, the dossier, whether use of the drug has created an affordability challenge for the State health care system or high out-of-pocket costs for patients, and, if so, how. Comments should be prepared and submitted separately for each drug.
Comments may be submitted to comments.pdab@maryland.gov, with the subject line (DOSSIER COMMENT- DRUG NAME).
The Board is accepting comments through July 3, 2025.
Request for Information (May 28, 2025):
- Cost Review Study Process- Request for Information begins May 28th, 2025 for Dupixent and Skyrizi. Please visit the RFI page for more information concerning submissions.
- There will be Technical Assistance Session for entities submitting data for the Request for Information on Friday, June 6, 2025, at 12PM ET to answer technical questions that submitters may have. You may register for the technical assistance meeting here.
